Both C12orf77 and TCL6 not only could inhibit tumor growth (T3 + T4 vs. T1 + T2) but also downexpressed in individuals with high levels of the pathologic stage, implying their negative roles in tumor development of ccRCC. This evidence concerns the gene LINC02909 and neoplasm.